Fda
-
FDA Commissioner Marty Makary Resigns Amid Pro-Life Pressure on Abortion Drug Policies
May 13, 2026 — Courts & Law
FDA Commissioner Marty Makary resigned following pro-life criticism, raising expectations for changes in abortion drug regulations under Trump.
-
5th Circuit Court Halts FDA’s Mail-Order Abortion Drug Permissions Citing Safety Concerns
May 6, 2026 — Explainers
5th Circuit Court Halts FDA’s Mail-Order Abortion Drug Permissions Citing Safety Concerns. Report, context, and sources from The Liberty Tribune.
-
5th Circuit Court Pauses FDA's Mail-Order Abortion Drug Permissions
May 6, 2026 — Courts & Law
The 5th Circuit Court has paused FDA's mail-order abortion drug permissions amid concerns over safety and financial interests of drug manufacturers.
-
5th Circuit Court Temporarily Blocks FDA Policy Allowing Mail-Order Abortion Drugs
May 3, 2026 — Explainers
5th Circuit Court Temporarily Blocks FDA Policy Allowing Mail-Order Abortion Drugs. Report, context, and sources from The Liberty Tribune.
-
5th Circuit Court Blocks FDA Policy on Mail-Order Abortion Drugs
May 2, 2026 — Courts & Law
The 5th Circuit Court temporarily halts a Biden-era FDA policy allowing mail-order abortion drugs, citing safety concerns and legal challenges from Louisiana.
-
Senate Republicans Investigate Mifepristone Makers Over Safety and Compliance Issues
Mar 26, 2026 — Explainers
Senate Republicans Investigate Mifepristone Makers Over Safety and Compliance Issues. Report, context, and sources from The Liberty Tribune.
-
Senate Republicans Investigate Mifepristone Manufacturers Over Safety Concerns
Mar 26, 2026 — Courts & Law
Senate Republicans are probing mifepristone manufacturers for alleged safety violations and mail-order abortion practices, raising concerns about compliance.
-
Trump DOJ Seeks Court Pause on Lawsuits Challenging FDA Approval of Abortion Pill Mifepristone
Mar 17, 2026 — Explainers
Trump DOJ Seeks Court Pause on Lawsuits Challenging FDA Approval of Abortion Pill Mifepristone. Report, context, and sources from The Liberty Tribune.
-
Trump DOJ Seeks Pause on Abortion Pill Lawsuit Amid Safety Review
Mar 16, 2026 — Courts & Law
The Trump administration's DOJ is calling for a pause on lawsuits challenging the FDA's approval of mifepristone, citing ongoing safety reviews.
-
Hawley Introduces Bill to Ban Mifepristone, Citing Health Risks
Mar 11, 2026 — Health
Sen. Josh Hawley has introduced legislation to ban mifepristone, citing health risks to women and unborn children, amid calls for stricter regulations.
-
FDA Commissioner Confirms Review of Abortion Pill Mifepristone Underway
Dec 10, 2025 — Health
FDA Commissioner Marty Makary announced a review of mifepristone will be released once completed, amid rising concerns over its safety and accessibility.
-
FDA Acknowledges Covid Vaccine-Related Deaths, Impacting Gen Z's Trust in Government
Dec 5, 2025 — Opinion
The FDA's admission of Covid vaccine-related deaths has intensified skepticism among Gen Z towards government institutions and health mandates.
-
The Government Gives Too Much Authority To Leftist Academics
Nov 7, 2025 — Education
The recent actions of the International Association of Genocide Scholars, which accused Israel of committing genocide in Gaza, have raised concerns about the.
-
Woman Coerced Into Abortion Sues FDA Over Mail-Order Drug Access
Oct 30, 2025 — Courts & Law
Rosalie Markezich, a Louisiana resident, is suing the U.S. Food and Drug Administration (FDA) for allegedly enabling a mail-order abortion scheme that she.
-
Inaction On Abortion Pill Puts Women At Risk Of Harm, Abuse
Oct 28, 2025 — Courts & Law
The Biden administration's decision to allow mail-order prescriptions for mifepristone, a medication used for abortion, has raised concerns about the safety of.
-
51 GOP Senators Urge HHS, FDA to Restrict Abortion Drug
Oct 10, 2025 — Courts & Law
Fifty-one Republican senators have called on the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) to take immediate.
-
Louisiana Demands FDA End ‘Illegal’ Mail-Order Abortion Pills
Oct 10, 2025 — Explainers
Louisiana Demands FDA End ‘Illegal’ Mail-Order Abortion Pills. Report, context, and sources from The Liberty Tribune.
-
Louisiana Demands FDA End ‘Illegal’ Mail-Order Abortion Pills
Oct 9, 2025 — Courts & Law
Louisiana Attorney General Liz Murrill and a Louisiana woman who survived abortion pill poisoning have filed a lawsuit against the U.S. Food and Drug.
-
Amid Review Of Deadly Abortion Drug, FDA Greenlights Copycat
Oct 2, 2025 — Explainers
Amid Review Of Deadly Abortion Drug, FDA Greenlights Copycat. Report, context, and sources from The Liberty Tribune.
-
Amid Review Of Deadly Abortion Drug, FDA Greenlights Copycat
Oct 2, 2025 — Courts & Law
The U.S. Food and Drug Administration (FDA) has approved a generic version of mifepristone, a medication widely used for abortions, manufactured by Evita.
-
Concerns Over Acetaminophen Use During Pregnancy Spark Debate
Sep 29, 2025 — Health
Recent discussions surrounding the safety of acetaminophen, commonly known as Tylenol, during pregnancy have intensified, particularly following remarks made by.
-
FDA Reviewing Mifepristone Safety Data, Says HHS Secretary Kennedy
Sep 4, 2025 — Health
Health and Human Services Secretary Robert F. Kennedy Jr. confirmed on Thursday that the U.S. Food and Drug Administration (FDA) is actively reviewing safety.